Science Explorer Back to mapMap
Discussion
Company · Lugano · Switzerland

Helsinn (Switzerland)

helsinn.comROR OpenAlex
Research works
86
▼ 65% vs 2018-21
Citations
1.8k
21.0 per fractional work
Top-10% rate
6.9%
all institutions 10.0%
Open access
34%
world 40%
International
67%
world 18%
Helsinn (Switzerland)

Not ranked overall: Helsinn (Switzerland) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Helsinn (Switzerland) work in?

In all years, 75% of research at Helsinn (Switzerland) is in Health Sciences, 16% in Life Sciences. Its largest fields are Medicine (73%), Biochemistry, Genetics and Molecular Biology (7%), Neuroscience (4%). It does 2.9× the world's share of Health Sciences.

Health Sciences: 64 fractional works · 74.7% of its workMedicine: 63 fractional works · 73.3% of its workSurgery: 22 fractional works · 25.6% of its workPharmacology: 5 fractional works · 5.6% of its workPhysiology: 5 fractional works · 5.6% of its workPathology and Forensic Medicine: 4 fractional works · 4.9% of its workAnesthesiology and Pain Medicine: 3 fractional works · 3.6% of its workDermatology: 3 fractional works · 3.3% of its workEpidemiology: 2 fractional works · 2.7% of its workOncology: 2 fractional works · 2.4% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 2.4% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 2.0% of its workRheumatology: 2 fractional works · 2.0% of its workPulmonary and Respiratory Medicine: 2 fractional works · 1.8% of its workPsychiatry and Mental health: 1 fractional works · 1.6% of its workOrthopedics and Sports Medicine: 1 fractional works · 1.5% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.5% of its workComplementary and alternative medicine: 1 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.9% of its workHematology: 1 fractional works · 0.9% of its workGastroenterology: 1 fractional works · 0.8% of its workOtorhinolaryngology: 1 fractional works · 0.7% of its workUrology: 1 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNursing: 1 fractional works · 0.8% of its workNutrition and Dietetics: 1 fractional works · 0.8% of its workHealth Professions: 0 fractional works · 0.4% of its workVeterinary: 0 fractional works · 0.2% of its workLife Sciences: 14 fractional works · 16.3% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 6.7% of its workMolecular Biology: 4 fractional works · 4.3% of its workCancer Research: 1 fractional works · 1.1% of its workMolecular Medicine: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNeuroscience: 4 fractional works · 4.3% of its workEndocrine and Autonomic Systems: 3 fractional works · 3.0% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 3.4% of its workPharmacology: 3 fractional works · 3.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 1.3% of its workImmunology: 1 fractional works · 1.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.6% of its workPhysical Sciences: 6 fractional works · 6.8% of its workChemistry: 3 fractional works · 3.0% of its workOrganic Chemistry: 1 fractional works · 1.5% of its workAnalytical Chemistry: 1 fractional works · 1.3% of its workInorganic Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 2 fractional works · 2.3% of its workElectrical and Electronic Engineering: 1 fractional works · 1.2% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workComputational Mechanics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workMathematics: 1 fractional works · 0.6% of its workStatistics and Probability: 1 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.5% of its workMaterials Chemistry: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 0.3% of its workSocial Sciences: 2 fractional works · 2.2% of its workDecision Sciences: 1 fractional works · 1.2% of its workStatistics, Probability and Uncertainty: 1 fractional works · 1.2% of its workBusiness, Management and Accounting: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 0.1% of its workArts and Humanities: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.1% of its workALL ITS WORKHelsinn(Switzerland)86fractional works, all years
Life Sciences16%Physical Sciences7%Health Sciences75%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine6373.3%
    2. Nursing10.8%
    3. Health Professions00.4%
    4. Veterinary00.2%
    1. Biochemistry, Genetics and Molecular Biology66.7%
    2. Neuroscience44.3%
    3. Pharmacology, Toxicology and Pharmaceutics33.4%
    4. Immunology and Microbiology11.3%
    5. Agricultural and Biological Sciences00.6%
    1. Chemistry33.0%
    2. Engineering22.3%
    3. Mathematics10.6%
    4. Materials Science00.5%
    5. Computer Science00.3%
    1. Decision Sciences11.2%
    2. Business, Management and Accounting00.4%
    3. Economics, Econometrics and Finance00.3%
    4. Psychology00.1%
    5. Arts and Humanities00.1%
    6. Social Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.31× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.31× its world share, 0 worksImmunology and Micro…Neuroscience: 4.37× its world share, 0 worksNeuroscienceEngineering: 0.29× its world share, 0 worksEngineeringHealth Professions: 0.83× its world share, 0 worksHealth ProfessionsMedicine: 3.25× its world share, 5 worksMedicineNursing: 2.24× its world share, 0 worksNursingArts and Humanities: 0.46× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 1.36× its world share, 0 worksBusiness, Management…Social Sciences: 0.10× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 4.4×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Neuroscience4.37×0 works
  2. Immunology and Microbiology3.31×0 works
  3. Medicine3.25×5 works
  4. Biochemistry, Genetics and Molecular Biology2.31×1 works
  5. Nursing2.24×0 works
  6. Business, Management and Accounting1.36×0 works
  7. Health Professions0.83×0 works
  8. Arts and Humanities0.46×0 works
  9. Engineering0.29×0 works
  10. Social Sciences0.10×0 works

Who are the top researchers at Helsinn (Switzerland)?

Ranked on the quality score, Sergio Cantoreggi, Alberto Macciocchi and Alberto Bernareggi lead among researchers whose main affiliation is Helsinn (Switzerland).

  1. 1 Sergio Cantoreggi Switzerland · #1,228,094 worldwide 895 citations · 22 works
  2. 2 Alberto Macciocchi Switzerland · #1,733,100 worldwide 1.8k citations · 27 works
  3. 3 Alberto Bernareggi Switzerland · #2,351,470 worldwide 1.9k citations · 78 works
  4. 4 Giada Rizzi Switzerland · #2,353,191 worldwide 1k citations · 44 works
  5. 5 Emanuela Lovati Switzerland · #2,620,179 worldwide 631 citations · 32 works
  6. 6 Pierfrancesco Ruffo Switzerland · #2,665,230 worldwide 407 citations · 29 works
  7. 7 Corinna Lanzarotti Switzerland · #2,775,767 worldwide 320 citations · 16 works
  8. 8 Giorgia Rossi Switzerland · #3,837,199 worldwide 477 citations · 31 works
  9. 9 Paolo D’Agostino Switzerland · #4,031,289 worldwide 81 citations · 24 works
  10. 10 Claudio Giuliano Switzerland · #4,045,659 worldwide 748 citations · 40 works
All ranked researchers at Helsinn (Switzerland)

What are the most cited papers from Helsinn (Switzerland)?

The most cited paper from Helsinn (Switzerland) is "NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016" (David S. Ettinger et al., 2016), with 739 citations. Next come "Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron" (473) and "Improved prevention of moderately emetogenic chemotherapy‐induced nausea and vomiting with palonosetron, a pharmacologically novel 5‐HT3 receptor antagonist" (405).

Most cited papers
#PaperReleasedCitations
1 NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016 David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network Open access Mar 2016 739
2 Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron Richard J. Gralla, M. Lichinitser, Stefan van der Vegt et al. · Annals of Oncology Open access 19 Sep 2003 473
3 Improved prevention of moderately emetogenic chemotherapy‐induced nausea and vomiting with palonosetron, a pharmacologically novel 5‐HT3 receptor antagonist Peter D. Eisenberg, Jazmin Figueroa‐Vadillo, Rosalio Zamora et al. · Cancer Open access 17 Nov 2003 405
4 A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy Matti Aapro, Steven M. Grunberg, George M. Manikhas et al. · Annals of Oncology Open access 10 Jun 2006 342
5 Palonosetron Exhibits Unique Molecular Interactions with the 5-HT3 Receptor Camilo J. Rojas, Marigo J. Stathis, Ajit Thomas et al. · Anesthesia & Analgesia Aug 2008 254
All 61 most cited papers, with filters and sorting

Which keywords describe research at Helsinn (Switzerland)?

By fractional works in all years, weighted toward what it does more of than the world: Acupuncture, Guidelines, Postoperative Nausea, Vomiting Prevention, Inflammation, Chemotherapy, Mitochondrial Dysfunction and Perioperative Care.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Acupuncture16▲ 285×3 topics
  2. Guidelines16▲ 39×2 topics
  3. Postoperative Nausea16▲ 998×1 topic
  4. Vomiting Prevention16▲ 998×1 topic
  5. Inflammation11▲ 5.3×18 topics
  6. Chemotherapy6▲ 10.0×12 topics
  7. Oxidative Stress6▲ 3.8×8 topics
  8. Mitochondrial Dysfunction6▲ 18×3 topics
  9. Perioperative Care5▲ 50×2 topics
  10. Antioxidants5▲ 13×3 topics
  11. Pharmacokinetics5▲ 20×3 topics
  12. Obesity4▲ 6.9×7 topics
  13. Cancer4▲ 3.6×12 topics
  14. Apoptosis4▲ 12×5 topics
  15. Chronic Pain4▲ 19×3 topics
  16. Cisplatin4▲ 431×1 topic
  17. Nephrotoxicity4▲ 108×1 topic
  18. Quality of Life3▲ 2.9×11 topics
  19. Pain Management3▲ 17×3 topics
  20. Postoperative Pain3▲ 39×3 topics
  21. Analgesia3▲ 48×2 topics
  22. Anesthesia3▲ 30×2 topics
  23. Dexmedetomidine3▲ 73×1 topic
  24. Regional Anesthesia3▲ 58×1 topic
  25. Sedation3▲ 39×1 topic
  26. Surgical Outcome3▲ 58×1 topic
  27. Cardiovascular Risk3▲ 8.9×2 topics
  28. Prognostic Factors3▲ 6.9×6 topics
  29. Cyclooxygenase-2 Inhibitors2▲ 77×1 topic
  30. Ghrelin2▲ 86×1 topic
  31. Leptin2▲ 86×1 topic
  32. Prostaglandins2▲ 77×1 topic
  33. Cytochrome P4502▲ 33×2 topics
  34. Enhanced Recovery2▲ 66×1 topic
  35. Surgical Care2▲ 67×1 topic
  36. Palliative Care2▲ 14×2 topics
  37. Cutaneous Lymphomas2▲ 112×1 topic
  38. Hiccups2▲ 469×1 topic
  39. Pharmacological Treatment2▲ 469×1 topic
  40. Teratogenicity2▲ 31×2 topics

Which research topics does Helsinn (Switzerland) publish most on?

By volume in 2022-now: Nausea and vomiting management, Regulation of Appetite and Obesity, Chemotherapy-induced organ toxicity mitigation and Cutaneous lymphoproliferative disorders research.

Nausea and vomiting management: 1 fractional worksRegulation of Appetite and Obesity: 0 fractional worksChemotherapy-induced org…0Chemotherapy-induced organ toxicity mitigation: 0 fractional worksCutaneous lymphoprolifer…0Cutaneous lymphoproliferative disorders research: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksAdipose Tissue and Metabolism: 0 fractional worksAdipokines, Inflammation…0Adipokines, Inflammation, and Metabolic Diseases: 0 fractional worksT-cell and Retrovirus Studies: 0 fractional worksOvarian function and disorders: 0 fractional worksMicroRNA in disease regulation: 0 fractional works
SurgeryEndocrine and Autonomic SystemsPathology and Forensic MedicineDermatology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nausea and vomiting management Surgery 1 works
  2. 2 Regulation of Appetite and Obesity Endocrine and Autonomic Systems 0 works
  3. 3 Chemotherapy-induced organ toxicity mitigation Pathology and Forensic Medicine 0 works
  4. 4 Cutaneous lymphoproliferative disorders research Dermatology 0 works
  5. 5 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  6. 6 Adipose Tissue and Metabolism Physiology 0 works
  7. 7 Adipokines, Inflammation, and Metabolic Diseases Epidemiology 0 works
  8. 8 T-cell and Retrovirus Studies Immunology 0 works
  9. 9 Ovarian function and disorders Reproductive Medicine 0 works
  10. 10 MicroRNA in disease regulation Cancer Research 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.2%not open65.8%

World: 40% of research is openly available.

with international co-authors66.7%domestic only33.3%

World: 18% is written across borders.

How has Helsinn (Switzerland)'s research output changed?

Output in 2022-2025 was 65% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Helsinn (Switzerland) as a percentage of every work published that year, 0.000026% in 2024.

still counting0.00050%0.0010%Helsinn (Switzerland)0.000013% in 2025200020102020

Fractional works of Helsinn (Switzerland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lugano

All research institutions in Lugano

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Helsinn (Switzerland). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.